论文部分内容阅读
通过1例肺炎伴冠心病、糖尿病和血脂异常患者的药物治疗过程的回顾和讨论,探讨药师如何依据患者的病理生理情况,结合相关指南和专家共识,与临床密切配合,寻找证据,合理选择药物,制定抗感染、抗冠心病、糖尿病和调血脂的治疗方案,预测患者的疗效和不良反应,制定细致周到的监护计划。在这例肺炎治疗中,药师与医生合作,经验性选择了抗感染药物,并根据治疗反应和病情变化及时调整抗感染方案,最终获得良好疗效。从实践中来看,药师介入药物治疗的全过程能得到临床认可,特别是在药物相互作用的鉴别、药物新信息的提供和患者用药教育方面深受临床欢迎,药师能够在治疗团队中实现自己的价值。
Through one review and discussion on the course of drug treatment in patients with pneumonia complicated with coronary heart disease, diabetes and dyslipidemia, this paper explored how the pharmacist can work closely with the clinical according to the patient’s pathophysiology, combined with the relevant guidelines and expert consensus to find evidence and select drugs rationally , Develop anti-infective, anti-coronary heart disease, diabetes and lipid-lowering treatment programs to predict the efficacy of the patient and adverse reactions, develop a meticulous care plan. In this case of pneumonia treatment, pharmacists and doctors, the empirical selection of anti-infective drugs, and timely response to treatment and disease conditions to adjust the anti-infective program, the final good effect. In practice, pharmacists are clinically recognized throughout the whole process of drug treatment, especially clinically welcomed in the identification of drug interactions, the provision of new drug information, and the education of patients’ medication, and the pharmacists are able to realize themselves in the treatment team the value of.